Latest filing published 11 Feb 2026 for SpyGlass Pharma, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Geoffrey B. Pardo, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in CVRx, Inc., Shoulder Innovations, Inc. and SpyGlass Pharma, Inc. In total, 3 filings cover trades dated from 2 July 2021 to 9 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 11 February 2026, reports a transaction in SpyGlass Pharma, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations